Fantastic news & congratulations to All!
Janssen own the data on CANVAS (cardio-renal in DKD) in our collaboration over the last few years in ~3000 patients. I get the feeling we also have good results coming from Ph2 for on treatment with Canafliglozin & CVD outcomes as well to get this news now.
We’ve obviously got the green light from Janssen to use this data for the FDA submission, so you can only see this as a massive positive & very good evidence on top of what we had 2 years ago in many more patients. Well done to all who held on.
Ann: Proteomics International seeks FDA approval for PromarkerD, page-5
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
87.0¢ |
Change
-0.025(2.79%) |
Mkt cap ! $113.8M | |||
| Open | High | Low | Value | Volume |
| 89.5¢ | 90.0¢ | 86.0¢ | $271.4K | 310.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | 86.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 3277 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
87.0¢ |
Change
-0.025 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 89.5¢ | 89.5¢ | 86.0¢ | 54719 | ||
| Last updated 15.56pm 14/06/2024 ? | |||||
| PIQ (ASX) Chart |